ACNP 60th Annual Meeting: Keyword Index

• Keyword Submission Number(s)

• (2R,6R)-hydroxynorketamine P87, P366

• (2S,6S)-HNK P60

• (R,S)-ketamine P50, P60

• 1H MRS P526

• 1H-MRS 60.2, P579

• 22q11 deletion syndrome 38.2, P459, P495, P529

• 22q11.2 deletion syndrome P570

• 2-AG P40

• 2-photon techniques P114

• 3-hydroxykynurenine P577

• 5-HT2A receptor 2.2

• 5-HT2A receptors P802

• 5-HT3 receptors 17.2, P574

• 5HT4R agonist P239

• 7 Tesla fMRI P483

• 7T fMRI P789

• A1 adenosine receptor P400

• a4b2 nicotinic acetylcholine receptors P668

• a4b2 receptors P706

• ABCD P63

• ABCD study 27.2, 28, 28.5, P164, P169

• abdominal obesity P335

• abstinence P598, P770

• Abuse Liability P584, P660

• Abuse Potential Study P315

• accelerated aging 27.3, P354, P362

• Acetylcholine 30.4, 56, P52

• Active Avoidance 35, P33

• Active Inference P719

• Acute and Chronic Stress 27.3

• Acute Stress P49, P87, P136, P251, P357, P437, P593, P698, P826, P829

• Acute Traumatic Stress P99

• Adaptive Behavior P348

• addiction 1.4, 34, 46, 46.1, 46.2, 55.3, P90, P625, P697, P701, P764

• addiction circuitry P601

• Addiction phenotypes 1, 1.2, P182, P199, P595, P687, P735, P778

• Adenosine signaling P117

• ADHD 9, 9.1, P105, P122, P127, P146, P397, P398, P399, P797

• Adiposity P453

• adjunctive treatment P510

• adjustment P434

• Adolescence P13, P30, P109, P143, P145, P157, P162, P169, P196, P206, P316, P341, P653, P704, P739, P774

• Adolescence- Critical Period P119, P121, P162, P537

• Adolescent 9.3, P249, P587, P817

• Adolescent Alcohol P161, P720, P747

• Adolescent Alcohol Use P691, P702, P774

• Adolescent Anxiety P159, P763

• Adolescent binge drinking P763

• Adolescent Brain Cognitive Development Study P801

• Adolescent Depression 43.4, P282, P325

• adolescent development P148

• Adolescent PTSD P130, P167

• adolescent schizophrenia P160

• adolescent stress P578, P787

• adult antisocial behavioral syndrome P204

• adult hippocampal neurogenesis P217, P259

• Adverse childhood events 14, P170

• adverse childhood experiences (ACE) P430

• Adversity P387

• aerobic exercise P108

• affective behavior 42, 56.4

• affective components of pain 42.2, P339

• affective neuroscience P172

• Affective theory of mind P143

• African American27.1

• age effects P104

• Ageing P15, P23, P24

• agency P503

• aggression 39.2, 47, P127, P210, P238, P635

• Aging 8.3, 33, P4, P26, P530

• Air Pollution 44, 44.3, 44.4

• Alcohol 17.4, 31.4, 46.1, 55.2, 55.3, 56.4, P249, P263, P604, P635, P664, P666, P672, P685, P686, P692, P700, P704, P707, P726, P771, P777, P778

• Alcohol and substance use disorders 17.3, 42.1, P205, P595, P611, P671, P703, P711, P769

• Alcohol consumption 34.2, P332, P632, P725, P778

• Alcohol dependence P184, P618, P681, P698, P762

• alcohol drinking P593

• Alcohol epigenetic marks 31.2, P234

• alcohol preference P750

• Alcohol Sensitivity P332

• alcohol use disorder 31.2, P285, P605, P610, P618, P648, P649, P680, P678, P741, P766, P767

• Alcohol Use Disorder - Treatment 17.1, 17.2, 34, 34.2, 34.3, P630, P639, P734

• Alcohol use disorder and drug addiction 25.3, 45.4, 46.3, P687, P704

• alcohol withdrawal P591, P644, P662, P683, P692

• ALDH-2 P639

• allopregnanolone 31, 31.3, 31.5

• allosteric modulator P330

• alpha oscillations P561

• alpha7 nicotinic acetylcholine receptor 6, 6.5, P617

• Altitude P281, P338

• Alzheimer’s dementia P791

• Alzheimer’s Disease 48, 56, 56.1, 56.2, 56.3, P2, P6, P7, P8, P10, P16, P19, P25, P306, P409, P782

• Ambiguity P826

• Amphetamine P446, P505, P576, P597

• Amygdala 29.4, 39.3, 43.3, 45.2, 46.1, P27, P41, P84, P89, P95, P236, P267, P337, P387, P447, P653, P747, P759, P793, P794

• amygdala-based networks43.4

• analgesia P366, P408, P732

• Analgesic P102

• Anandamide 42.4

• Androgen P12

• anhedonia 51.1, P128, P247, P282, P310, P324, P341, P388, P789, P803

• Animal Models 25.3, 46.2, 57, 57.2, P338, P463, P661, P725, P730

• anorexia nervosa 14, 14.1, 14.3, P187, P189, P196

• Antagonist Ligands P590

• anterior cingulate 37.5

• Anterior Cingulate Cortex (ACC) 35, 35.4, 42.2, 55.2, P33, P175, P260, P331, P339, P441, P528, P769

• Anterior insula 35.2, P260, P578, P604

• anterior limb of the internal capsule 35.5

• anthranilic acid P577

• anticholinergic P573

• Anticholinergic medication burden P477, P573

• Antidepressant 21.4, P12, P218, P297, P315, P369, P390, P400

• Antidepressant Induced Mania P302

• antidepressant pharmacotherapy 8.4

• Antidepressant Treatment P394

• Antidepressant Trials 8.2

• Antidepressants 8.1, P183, P333, P448

• anti-gliadin antibodies (AGA) P569

• Anti-inflammatory P366

• anti-inflammatory cytokines 34.3

• Antipsychotic P463, P493, P507, P547, P559

• Antipsychotic agents P453

• Antipsychotic drugs P510

• Antipsychotic response 60, P506

• Antipsychotic Treatment P17, P373

• Antipsychotic-naïve first-episode schizophrenia P506, P542

• antipsychotic-naive schizophrenia P526

• Antipsychotics P458, P509, P563, P577

• antisocial personality disorder P204

• Anxiety 9, 9.2, 22, 37.4, P7, P32, P37, P43, P54, P58, P78, P90, P222, P239, P433, P633, P747, P816, P828

• Anxiety & PTSD 31, P42, P55, P64, P88, P89

• Anxiety and Depression P80, P177, P234, P309, P356, P786

• Anxiety and stress P11, P39, P41, P86, P140

• Anxiety circuitry 22.4, P69, P331

• Anxiety Development 26.2

• Anxiety Disorder P92

• anxiety disorders P28

• anxiolytics P283

• Apoptosis P558

• appetite P357

• Approach/Avoidance P73, P745

• aromatase P656

• arousal 46.4

• Arterial Spin Labeling P148

• Artifical transcription factors P723

• artificial intelligence 3, 3.1, P127

• associative learning P27, P655, P785

• Astrocyte P301, P637, P713, P813

• astrocyte-derived exosomes (ADE) P248

• astrocyte-neuron interaction P597

• astrocytes P117, P358, P717, P754

• astrogliosis P425

• Atomoxetine P208

• Attention P26, P208, P693

• attentional bias P203

• Atypical antipsychotics P480, P491

• auditory P525

• Auditory cortex P467

• Auditory fear conditioning P33, P95

• Auditory hallucinations P467, P473

• Auditory Mismatch Negativity P470, P562, P574

• Auditory perception P535

• auditory processing P460

• auditory steady-state response P562, P574

• Auditory Striatum P535

• augmentation strategies 8

• Autism 11, 16.2, 38.4, P124, P129, P137, P142

• autism spectrum disorder 16.4, 36, P112, P120, P126, P150, P154, P163, P418

• Autism spectrum disorder and related syndromes 16, P171, P512

• Automated Facial Affect Recognition P495

• automated natural speech analysis P98

• avoidance P292

• avoidance and escape P41

• avolition P821

• AXS-05 P245

• Aβ P306

• baclofen P173

• balloon analogue risk task P695

• Bariatric Surgery P197

• Basal Ganglia 35.3, P413, P823

• base excision DNA repair P381

• basolateral amygdala 22.2, P36, P69, P665, P737

• BDNF P320

• BDNF Val66Met P30, P42

• bed nucleus of the stria terminalis 39.2, P825

• behavior P570

• behavior predictor P105

• behavioral activation system P200

• behavioral economics 20.3

• behavioral flexibility 35, 57, P591

• behavioral genetics P714

• behavioral inhibition P313

• behavioral inhibition system P200

• Behavioral Pharmacology 34.2, P627

• Behavioral Tasks P802

• behavioral variant frontotemporal dementia P791

• Behaviors P317

• Biased signaling 42.3, P600

• big data 37.3, P17

• big data analysis 30.2, 49

• Binge alcohol use P645

• Binge eating P188, P193

• binge-drinking 34.4

• Binge-eating disorder P193

• Bioenergetics P322, P338

• bioinformatics P355, P550, P611

• Biomarker Fingerprint P572

• Biomarker Prediction P140, P318

• biomarkers 21, 31.5, 36, 60.4, P19, P29, P163, P369, P375, P394, P496, P749

• biostatistics 3

• biotypes 60.4

• bipolar depression P305, P319, P373

• Bipolar Disorder 9.1, 42.4, P17, P228, P236, P238, P255, P270, P275, P284, P288, P302, P304, P307, P321, P332, P362, P363, P375, P381, P390, P397, P398, P399, P504, P575

• Bipolar I & II disorder P373

• Bisque P276

• Blood pressure P72

• Blood-Brain-Barrier 4.2, P504, P530

• BNST P86, P104, P290

• body dysmorphic disorder P439

• Body mass index P186

• body perception P187

• body self 2.4

• BOLD fMRI signal P286, P793, P796

• Borderline Personality Disorder P447, P448

• Brain 23, 23.4, P43, P93, P777

• Brain age P1, P20, P394

• Brain Anatomy P277

• brain circuitry P36, P489

• brain connectome P593

• Brain development 33, 54.1, P110, P117, P149, P168, P292, P416

• brain endophenotypes 7

• brain imaging 9.1, 27, 55, P551

• brain microvascular endothelial cells P329, P504, P530

• Brain Stimulation 50.5, 55

• Brain Structural Connectivity P565

• brain structure P675

• Brain Transcription 39.5, P220

• Brain-based Predictor P799

• Brain-enriched exosomes P38

• Brainstem 56.1, P698

• breast cancer chemotherapy P180

• bulimia nervosa 14, 14.2, 14.3, P193

• Buprenorphine P682

• CA1 P486

• calcium imaging P754, P823

• callous/unemotional P202

• Callous-unemotional traits P143

• cAMP signalling P413

• canabinoid receptors P755

• Cannabidiol P424, P616, P742, P805

• Cannabinoids P26, P620

• cannabis 13, 13.2, 13.3, 42.4, 55.4, P111, P481, P558, P606, P631, P633

• cannabis use P587, P615

• cannabis use disorder 13.5, 55, 55.5, P179, P502, P583, P587, P693, P695, P749

• Cardiolipin P297

• Cardiometabolic Risk P44, P226

• cardiovascular P29

• Cardiovascular Physiology P53, P530

• catalepsy P732

• catatonia P533

• causal discovery analyses P150

• CBT and antidepressants 21.3

• Cell- and Circuit-selectivity P177

• Cell Type Specific 29.2, P91, P468

• Cell-free DNA P375

• Cell-type diversity P4

• central amygdala P681, P711

• Central autonomic network P326

• Central Nervous System P509

• cerebellum 28.5, P97, P321, P503

• c-Fos P437, P607, P722, P747

• Chemobrain P5

• chemogenetics 44.4, P114, P212, P277, P594, P626, P676, P781, P808

• chemotherapy-induced peripheral neuropathy P420

• Child abuse and neglect P110

• child maltreatment P170

• child offspring P405

• Childhood Adversity 24, 54.4, P44, P149, P296, P825

• childhood anxiety P85

• childhood maltreatment P389

• Childhood maltreatment exposure P674

• Childhood Onset Bipolar Disorder P288

• Childhood trauma 14.4, P64, P110, P130, P164, P748

• Childhood-onset schizophrenia P160

• Children P111

• Children and Adolescents 9, 54.4, P131

• choice P602

• Choline analog P407

• cholinergic interneuron P207

• cholinergic system 56.3, P4, P256, P407

• CHRNA5 P686

• chromatin P80

• chromatin modifications P708

• Chronic corticosterone P340

• chronic pain P417, P608, P730

• chronic social defeat P221, P290

• chronic stress P212, P265, P300, P301, P344, P395

• Chronic unpredictable mild stress P320, P340, P343

• cingulo-opercular network P28

• circadian P409

• circadian rhythm P180, P383, P401, P532, P739

• circRNA P634

• Circuit Function in Humans 37.2

• circuit optogenetics 45, P814

• Circuit-function 54.1

• Circuitry-based approach 37.2

• circuits 39, P327, P672

• Circulating cell-free mitochondrial DNA 28.3, P211, P255

• Circulating mitochondrial DNA P275

• Claims database P541

• claustrum P751

• clinical assessment P516

• Clinical Development 3.3

• Clinical heterogeneity 38.4, P226, P288

• clinical high risk for psychosis 36

• Clinical interventions P206

• clinical outcome assessments 36

• Clinical predictors P494

• Clinical psychiatry P272

• clinical psychopharmacology P507

• Clinical trial 13, 37.3, P28, P328, P368, P386, P418, P630

• Clinical Trial Rating Methods P100

• clinical trials methodology P160

• clozapine 60.4, P568, P579

• clozapine response 60

• Cluster Analysis P428

• CNS Clinical Trials 3, 3.3, 36, P272, P525, P554, P572

• coactivation pattern analysis P389

• cocaine 10.2, 29.3, P175, P596, P622, P636, P637, P640, P643, P656, P713, P751, P761, P764, P813

• cocaine addiction P609, P613, P657, P659, P752, P759, P772, P780

• cocaine and opioid use disorders P693, P723

• cocaine seeking P770

• cocaine self-administrationP629, P714, P740, P743, P756, P768

• cocaine self-administration and reinstatement P607, P722

• cocaine sex differences 10, 10.4

• cocaine use disorder P583, P590, P671, P674, P675, P740, P743, P804

• cocaine-seeking behavior P634, P740

• Cognition 1.4, 6.2, 13.2, 17.2, P5, P9, P13, P51, P374, P406, P455, P487, P539, P564, P572, P573, P617, P798, P813, P814

• cognitive and affective neuroscience P670

• cognitive behavioral therapy 51.3

• cognitive control 9.2, 18, 57, 57.4, P143, P208, P209

• cognitive control network 26.4, P804

• Cognitive Decline P12, P664

• cognitive development P166

• Cognitive dysfunction P814, P827

• cognitive flexibility 16.3, 57.2, P324, P346, P353, P710, P751

• cognitive function P591

• Cognitive Functioning P116, P477, P517, P537

• Cognitive impairment associated with schizophrenia P450, P462, P560, P562, P574

• Cognitive impairments P499

• cognitive neuroscience P196

• Cognitive performance 6.3, P538

• cognitive skills P139

• Cognitive symptoms P430

• Cognitive training P610

• Commercial insurance P541

• communication 58

• Comorbidity 17, P440

• Complement component 4 52.4

• complement pathway 52.4

• compulsion P604

• Compulsive behavior 1, 1.2, 1.4, 50.3, 50.4

• compulsive drug intake P641

• compulsivity 1.1, 1.3, P194

• Computational Methods 22.5, P461, P829

• computational modeling P433, P652, P719

• computational models of decision-making P310

• Computational Neuroscience 3.2, P807

• computational psychiatry 35.3, P324

• Computational Reinforcement Learning Model P55, P800

• Computer vision P421

• Computerized Cognitive Training P576

• COMT inhibitor P443

• conditioned fear memory P36, P69

• conditioned place preference P627, P642, P651, P656

• conduct disorder P204

• conflict monitoring 22.5

• connectivity P22

• Connectivity gradients P441

• consortium P736

• Context P748

• contextual fear P50

• contingency management P179

• Convulsion-like model P407

• coping P266, P728

• copy number variants P512

• corollary discharge P503

• Cortical atrophy P32

• cortical circuit development P543

• Cortical Development P138

• cortical excitability P431

• cortical excitation-inihbition balance P232

• cortical interneurons P471

• Cortical Myelination P107

• cortical thickness P186

• cortical thinning 52.4

• corticolimbic 42, P766

• corticosterone P180, P269

• Corticosterone response to stress P340

• Corticostriatal circuit P266

• Cortico-striatal connectivity P441

• Corticotropin-releasing factor (CRF) P252

• Cortisol P58, P68, P251, P760

• Cortisol response to stress P357

• counting Stroop Functional MRI (fMRI) P203

• Court-involved youth P206

• COVID-19 6, 6.2, 23, 23.2, 23.3, 23.4, 23.5, 54, P11, P99, P140, P151, P178, P183, P253, P272, P434, P440, P544, P680, P700, P826

• craving 20.5, P588, P610, P639, P678

• c-reactive protein P498

• creativity P824

• CRF P35

• CRH P387

• CRH+ neurons P114

• CRISPR P756

• CRISPR/dCas9 29.3

• cross validation P511

• CSF P178

• CSF Biomarkers P411

• CSF sTREM2 P306

• cue P780

• Cue Reactivity P636, P760

• cue reinstatement P624

• Culture P333

• Cyberball P812

• cyclic AMP P369

• Cyclic peptide P553

• cytokines 52.3, P24, P38, P178

• cytoskeleton P536

• D1 dopamine receptors 57.5, P478, P535

• D2 dopamine antagonists P507

• D2 dopamine receptor 22.2, P207, P534

• D2 Receptor P547

• dACC P284

• Dallas Heart Study P1

• D-amino acid oxidase P462

• D-amino acid oxidase inhibitor P560

• daridorexant P582

• DAT/NET inhibition P619

• Data science 3.2

• DBS P759

• Decentralized Clinical Trials 3.3

• Decision Making 22, 22.3, 22.5, 35.3, 46.4, P196, P410, P587, P622, P635, P706, P787, P823, P826

• declarative memory P8

• Deconvolution P276

• deconvolution microscopy 30

• Default mode network (DMN) 2.3, P74, P467, P475, P814

• defensive and motivated behaviors P89

• delay discounting 22.3, P198

• delta opioid receptor P665

• delta9-tetrahydrocannabinol P589, P805

• Dementia 37.3, 48, 48.2, 48.4

• Dementia-related psychosis 48.3

• Dendritic arborization P795

• dendritic morphogenesis P536

• dendritic remodeling P87, P598

• Dendritic spines P622, P663

• dentate gyrus P529

• Depression 2.2, 2.5, 4, 4.2, 10.5, 16.3, 17.2, 21, 21.1, 21.4, 25.2, 37.3, 43, 43.3, 46.4, 51, 51.1, 51.3, 56, 56.2, P11, P20, P48, P97, P176, P211, P221, P229, P230, P233, P238, P239, P240, P243, P244, P247, P252, P261, P265, P268, P280, P291, P295, P299, P306, P316, P324, P327, P333, P336, P342, P343, P352, P368, P377, P390, P404, P406, P606, P762

• Depression and Anxiety 10, 37.2, P109, P242, P338, P379, P382

• depression and obesity P386

• Depression Inflammation Cytokine 4.4, P297, P361, P370

• depression recurrence risk P261

• Depression-CVD comorbidity 25.4

• depressive disorders P169

• depressive symptoms 51.2, P298, P359

• development 4.1, P640

• Developmental 54, P172, P704

• Developmental Psychopathology P43

• Developmental trajectory P534

• Developmental transcriptome 11.1

• Diagnosis P575

• Differential susceptibility P140

• Diffusion Tensor Imaging (DTI) 27.1, P57, P85, P197, P376, P586, P752

• Diffusion Weighted Imaging P487, P565, P605

• Digital phenotyping P214

• digital psychiatry P228

• Dimensional child psychopathology 26.4, 28.5

• dimensional psychopathology P85

• dimensions 38.3

• dimethyltryptamine P365

• Discrimination 27

• Disease risk prediction 3.1

• disinhibition 1, 1.2

• disruptive behavior disorders P156

• diverse populations 1.2

• diversity 40, 49, P790

• DLPFC P567, P760

• DNA 48.1, P566, P575

• DNA hydroxymethylation P61

• DNA Methylation 27, 31, P61, P227, P362, P377, P479, P778

• DNMT P755

• Dopamine 6.2, 22.4, 29.3, 30.4, 39.3, 44.4, 51.1, P6, P47, P109, P129, P153, P165, P177, P191, P205, P268, P282, P330, P340, P388, P413, P427, P446, P535, P547, P597, P658, P679, P689, P691, P709, P710, P823

• Dopamine (D2, D3) receptors P699

• dopamine D3 receptors P642, P770

• Dopamine D4 Receptor P590

• Dopamine function P668

• dopamine receptor type 2-expressing striatal medium spiny neuron P52

• Dopamine receptors 45.3

• dopamine transporter 42.4

• Dopaminergic system P650

• dorsal caudate P165

• Dorsal Hippocampus P108, P269, P768

• dorsal raphe 56.2, P194

• Dorsal Root Ganglia P419

• Dorsal striatum P662, P702

• dorsal visual stream P439

• dorsolateral prefrontal cortex 6.5, 37.5,P484, P502

• dorsolateral striatum 10.4

• Dorsomedial striatum 50.3

• Doublecortin P217

• DRD1 P679

• DRD2 P679

• DREADDs P109, P277

• Drosophila P229

• drug abuse P709, P720

• Drug Development P225, P547

• Drug Discovery - new approaches P355, P472, P563

• drug discrimination P584

• Drug metabolism P664, P694

• Drug Relapse 45.3, P657, P661

• drug repurposing P183

• drug self-administration 34.4, 55.4, P623

• D-serine P462, P514, P525

• Dual orexin receptor antagonist 20.3, 20.4, 20.5, P185, P581, P582, P584, P764

• duloxetine P367

• dynamic causal modeling P260

• Dynamic Functional Connectivity P92, P353

• Dynorphin 45.2

• early adolescence P471

• early childhood P135

• Early identification of risk P288

• Early life adversity 25.3, 27.3, 54.2

• Early life stress 10, 16.3, 25.2, 28, 29, 29.5, 44, 44.5, 54.1, 54.3, P44, P132, P134, P254, P294, P316, P675, P684, P700

• early onset psychosis P512

• early psychosis P454, P474, P538, P555, P556, P565

• early-life adversity 10.3, 25.4, 29.5, 54, 54.3, P108, P128, P157, P665, P737

• early-life stress P48, P430

• eating behavior P196

• Eating disorders 11.4, 14.3, 14.4, P186

• ecological momentary assessment P593, P738

• EEG 9, 9.1, 13.2, 21.4, P313, P522

• EEG biomarkers 9.2, 26.2, 57, 57.2, P314, P476

• EEG connectivity P522

• EEG electrophysiology P436

• EEG/ERP electrophysiology 37.4, 57.4, P786

• effectiveness 8, 8.3

• Efficacy and Tolerability P283

• effort based decision making task P122, P310, P498

• Effort Discounting P324

• ehmt2 P618

• electric field modeling P232, P323, P810

• electroconvulsive therapy P289, P374, P406, P810

• electroencephalography P552

• Electronic cigarette (e-cigarette) P589, P660, P716

• electronic health record (EHR) P62

• electrophysiology 11.2, 45, P182, P205, P216, P472, P539, P702, P720, P751

• EMA P632

• embryo screening P540

• Emergency Department P65, P788

• emotion P465

• Emotion Circuitry 14.2

• emotion processing P164

• emotion regulation P820

• Emotional dysregulation P72

• Emotional empathy P528, P690

• Emotional regulation 14, 25.3, 43.4, 53.2

• Emotional stress P780

• emulated target trial P312

• endocannabinoid system P59, P111

• Endocannabinoids P40, P49, P468, P696

• endophenotypes 38, 38.5

• Endothelial function P72

• engram P7

• environment P162

• environmental risk factors P37

• EphA2 Receptor P356

• Ephrin P356

• epidemiology 48.2, P120, P133, P544, P550

• epigenetic age acceleration P362

• Epigenetic biomarkers 25.1

• Epigenetic Modification 16.2, P75

• Epigenetics 2.2, 10.3, 16, 16.4, 16.5, 25, 29, 29.2, 29.5, 31.2, P3, P36, P80, P113, P294, P375, P479, P629, P664, P708, P715, P744, P756, P778

• epigenomics P269

• epilepsy P415, P423

• equity 40

• ERP P525

• Error processing P436, P797

• Escitalopram P305

• Esketamine P83

• estradiol 10.4, 53.3, P327, P351

• estrogen receptor P327

• estrogen therapy 53

• ethanol P599, P644

• ethanol intake P757

• ethics 12, 32

• eugenics P540

• event-related potentials 9.3, P187, P470, P669, P811

• evidence-based approach P773

• EWAS P377

• excessive sleepiness 56.1

• excitability P75

• excitation-inhibition balance P471

• executive function 54.2, P8, P172, P195

• Exercise P3

• Experience dependent plasticity 54.1

• experimental design 58

• Experimental Therapeutics 47, P476

• exploration P792

• explore-exploit dilemma P719, P792

• Exposure therapy P54

• extended amygdala P39, P825

• Externalizing behavior 54.4

• externalizing disorders P822

• Extinction P66, P657

• Extinction and Reinstatement P596

• Extinction learning P54

• extracellular matrix P301, P628

• Extracellular vesicles P248, P830

• extrasynaptic GABA receptors P235

• eye-blinks P679

• F-18 PET Imaging P58

• Facial emotion processing P304, P588, P670

• factor analysis P289

• familial risk P363, P397, P398, P399

• familial risk of bipolar disorder P288

• fast scan cyclic voltammetry P650, P658

• Fast-acting Antidepressant P311

• Fear P27, P41, P84, P239

• Fear conditioning P52, P60, P89, P130, P347

• Fear conditioning and extinction P31, P54, P55, P59, P76, P209, P444

• Fear extinction P87, P92

• fear generalization P40

• Fear learning 56.4, P30, P75, P96

• Fear physiology P444

• fear-potentiated startle P130, P185

• Fecal microbiota transplant P334

• Feedback negativity 57.2

• Feeding 30, 30.3, P509

• feeding behavior 11.3, P195

• females P309

• Fentanyl 20, P598, P647, P718

• fetal alcohol spectrum disorder P138, P664

• Fetal Brain Development 44.2

• Fetal Origins 25.1

• fiber photometry P90, P136, P347, P446, P534, P676

• fibromyalgia P176

• first episode 13.2

• first episode psychosis 13.3, P455, P474, P505, P515, P516, P531

• first-episode schizophrenia P524

• FKBP5 P45, P170

• Flanker Task P670

• fluoxetine 50.2, P292

• FMR1 premutation P428

• fMRI Biomarkers P304

• fMRI Effective Connectivity P439

• fMRI Functional Connectivity P593

• fMRI resting state P148, P726

• fNIRS P631

• focused ultrasound P729, P793, P811

• food craving P335

• food deprivation P750

• food intake P600

• fragile X syndrome P173

• Free water imaging P376, P457

• Frontolimbic network P111

• Frontoparietal Network P814

• frontostriatal circuitry P565

• frontotemporal dementia 48

• Frustration P799

• Frustrative Non-Reward 47, P403

• functional brain network P455

• functional connectivity P74, P112, P459, P469, P568, P825, P828

• functional disability P319

• Functional imaging 30.3

• functional impairment P275, P298

• Functional MRI (fMRI) 2.5, 7, 9.1, 14.4, 26, 27.1, 37.2, 37.4, 51.1, 53, 55.3, 60.3, P28, P59, P70, P76, P92, P137, P168, P193, P241, P243, P253, P277, P291, P307, P325, P326, P353, P403, P418, P448, P551, P570, P571, P625, P652, P690, P769, P788, P797, P804, P822

• functional near-infrared spectoscopy 26

• functional neuroimaging 14.3, 53.3, P55, P444, P456

• functional outcomes P450

• functional variants P220

• Functioning P359, P362

• fusiform face area (FFA) P551

• Future orientation P119

• G9a P618

• GABA P163, P222, P223, P271, P423, P520, P579, P681

• GABA neuron P117, P300

• GABAA 31.2

• GABAA receptor positive allosteric modulator P415

• GABA-A, positive allosteric modulators 31.4, P235, P415

• GABAergic interneurons P459, P464, P489

• GABAergic system P407

• gambling 46, 46.4

• gambling disorder P804

• gaming disorder 1.1

• gamma oscillations P552

• GDF-15 P354

• Gender differences 58

• Gene co-expression networks 4.4, P96

• gene expression 10.2, 28.5, 51.4, P262, P466, P482, P757

• gene level analysis P381

• gene priming P708

• generalized anxiety disorder P32

• genetic architecture P445

• Genetic Disorder P105

• genetic risk factor 28.4

• Genetic variation P199, P302

• Genetically encoded sensor 30.5, P207

• genetics 38, 38.5, P91, P336, P499

• Genetics of depression P220, P226

• genome-wide association study 13.5, P753

• Genomics 25, 25.4, 38.5, P94, P146, P349, P566, P736, P798

• geriatric P17, P368

• geriatric depression 8, P271

• Ghrelin P44, P251

• Gliadin P569

• gliosis P425

• Globus Pallidus P754

• GLP-1 receptor P726

• GLT-1 P717

• glucocorticoid P45, P49, P278

• glucose metabolism P2

• glutamate 60.2, P244, P254, P265, P400, P427, P515, P813

• glutamate GABA 52.5, P404, P526

• Glutamate homeostasis P87

• glutamate receptor P466

• glutamate transporter (EAAT3) P343, P446, P619

• glutamatergic synapses P697

• glutamatergic transmission P343, P591

• glutathione P567

• gluten P569

• Glycocalyx P542

• glycosylation P451

• goal-directed behaviors P754

• Gonadal Hormones 10

• GoNoGo P207

• GPCR P369, P417, P553, P563

• GPS P214

• gray matter volumes P147

• GRIN1 mutation P431

• GRIN-related disorders P431

• Gut Microbiome 44, 44.4, 53.2, P20, P129, P316, P647, P795

• Gut-Brain Axis P334, P740

• GWAS P184, P226, P694, P746

• gyrification P139

• habenula 35.3, P380

• habit 50.4, P754

• hallucinogens 2.2

• haplotype association mapping P735

• harm avoidance 35.4

• Harm reduction P616, P660

• HDAC inhibitors P5

• HDAC4 P234

• head-to-head clinical trial 8.1

• Health Disparities 59, P19, P206

• health policy 59

• Health services P99

• healthy individuals P818

• heart rate variability 53, 53.2, P126, P326

• Hedonic Ingestion P190

• hemodynamic effect P286

• Hemoglobin A1C P1

• Heroin 20, 20.2, P625, P628, P673

• heroin self-administration 29.2, 45, 45.3, P615, P650, P676, P717

• heterogeneity P298

• high fat diet P116, P192

• High potency THC P616

• Higher criticism P74

• High-Throughput P829

• hippocampal connectivity 21.2

• Hippocampal subfields P32

• Hippocampal-prefrontal P459

• Hippocampus 11.4, 54.3, P3, P6, P7, P12, P22, P41, P166, P264, P299, P396, P456, P486, P528, P529, P530, P748, P788, P807

• Hispanic/Latinos P333

• Histone acetylation P75, P461

• histone deacetylase 16, 16.2, 16.4, 16.5

• Histone methylation 16, 16.3, P221, P461

• histone variants P708

• historical loss 51.2

• HIV P170, P430, P770

• HIV associated neurocognitive disorder P815

• Homer1 P634

• Homosexuality 24

• hormonal contraceptive use P81

• HPA axis 10.5, P136, P783

• Human Clinical trial 8.3

• Human Genetics P147, P171, P746

• Human Neuroimaging 41.3, P58, P79, P162, P167, P201, P812

• human postmortem brain P276, P765

• human postmortem brain tissue 29.4

• Human transmission 30.5

• Hydroxynorketamine P233

• hyperalgesia P676

• hyperarousal 6.4, P39, P130

• hyperthermia 4.4

• Hypobaric hypoxia P338

• hypochondriasis 1.1

• Hypofrontality P712

• hypothalamic circuit 30

• hypothalamic-pituitary-adrenal axis P741

• hypothalamus P136, P212, P559

• Hypoxia 23.2

• ibudilast 34.3

• ICD-11 1.1

• IL-6 P118

• imaging 54, P801

• Imaging-genetics P726

• immediate early gene P612, P635

• Immune P170

• Immune Biomarkers P38, P412, P674

• immune cells P482

• immune modulation P310

• Immune responses P230, P379

• immune system P352, P830

• Immunity 4

• Immunity & neurodevelopment by sex P345

• immunohistochemistry P188

• Implicit association test P144

• impulse control 1

• impulsive sensation seeking P270

• impulsivity 22, 46, 46.2, 46.3, 46.4, P90, P153, P156, P199, P203, P208, P304, P307, P588, P693, P761

• in vitro fertilization P540

• In vitro neuronal differentiation P303

• in vivo P47

• in vivo calcium imaging 11.3, P39, P40, P50, P67, P438, P597

• In vivo Imaging 30.2, 30.4, 41, P422

• In vivo microscopy 50.2

• incentive motivation P697

• inclusion and exclusion P790

• Independent Component Analysis P784

• Indirect Pathway P534

• individual differences P214

• individual variability P418, P497

• Individual vulnerability 46.1

• Induced pluripotent stem cells (iPSCs) P123, P401, P504, P539

• infant electroencephalography P141

• inflammation 44.2, 51, 51.1, 52, 52.2, 52.3, 52.4, P241, P316, P352, P395, P412, P498, P569, P789

• Inflammatory Markers 51.3, 51.4, 52, P545

• Inhibition P79

• Inhibitory control P26, P287, P707, P801

• innate behavior P256

• insomnia 20.5, 51, 51.4, P99, P581, P606, P764

• insomnia disorder P582

• instrumental learning P663

• Insula 55.2, P145, P237, P456, P760

• insulin P191

• insulin resistance P22, P312

• intellectual disability P124

• interactions 44

• Interbrain Synochrony P809

• Intergenerational Transmission P149

• Intergenerational transmission of trauma P110

• Interleukin-8 P305

• Intermittent Access self-administration 20.3, P643, P659

• internalizing disorders 54.4, P822

• Interpersonal Violence P63

• inter-subject correlation P625

• intravenous drug self-administration P608, P624, P642

• intrinsic EEG activity 60.4

• intrinsic excitability 29.2

• intrinsic motivation P571

• ion channels P308, P431, P539

• irradiance P286

• irritability 47, 53, 53.1, 53.2, 53.3, P674

• Irritability/Aggression P200, P202

• IV- Ketamine P247

• juvenile critical period P108

• juvenile social isolation P787

• Kaplan-Meier Survival Curve P1

• kappa opioid receptor 45.2, P278, P379, P766, P779

• Kappa Opioid Receptor Antagonist P731

• Ketamine 25.2, 50.3, P66, P68, P102, P233, P293, P328, P400, P402, P405, P458

• Ketorolac P102

• kinase inhibitor P344

• kinome array P550, P559

• Kinomics P322

• kinship 11, 11.2

• kratom P667

• Kv3 channels P460

• Kynurenic acid 6.3, 6.4, 6.5, P557, P572

• Kynurenine pathway 6, 6.3, 6.4, 51.3

• L1000 P262

• Lactate P284

• Language P496, P654

• Late-life Depression 8.1, 8.2, P9, P11, P227, P248, P354

• latency of acoustic startle P545

• Latent class analysis P238, P289

• Lateral Habenula 42.1, P73, P194, P293, P752

• Lateral hypothalamus 30.3, 39.4, P194

• lateral septum 11, 11.2, 11.3, 11.4

• Latin America P736

• LC-NE P19

• Learning Health System P555

• Learning Rate P719

• lemborexant P585

• Leptin P22, P44

• Leptin Resistance P509

• leukocyte telomere length 4.3

• levomilnacipran P367

• LgDel P570

• Lifetime stress 44.3, P456

• linguistic markers P98

• lipid oxidation P567

• lipid rafts P369

• lipids P189, P361

• lithium P381, P390

• local field potentials 57.3

• Locus coeruleus (LC) P9, P10

• Long Access self-administration 20.2

• Long Term Potentiation P462

• Long-acting injectable antipsychotics 19, 60.3, P541

• longitudinal analysis 26.2, P135

• Longitudinal MRI P107, P810

• longitudinal study P85, P763

• Loss 39.5

• LQFM032 P407

• LSD P682, P796

• LSD microdosing P818, P824

• lumateperone P319

• M5 muscarinic receptor P330

• Macaque P165, P794

• machine learning 21.4, 39.4, P112, P318, P474, P496

• machine learning classification P198, P421, P473, P542

• Machine learning clustering 45.4

• Macrophage 52.2

• MADRS P223

• Magnetic Resonance Imaging (MRI) 16.5, 23, 27.2, 37.3, P34, P115, P156, P261, P364, P392

• magnetic resonance spectroscopy 34.3, P163, P176, P404, P520

• Magnetic seizure therapy P289

• magnetoencephalography P454, P531

• Major depression P215, P226, P396, P575

• Major Depression Disorder P281, P314, P322, P350, P384, P389, P401

• Major Depressive Disorder (MDD) 21.2, 21.3, 31.5, P51, P66, P83, P94, P179, P218, P222, P223, P224, P235, P241, P245, P246, P251, P259, P264, P271, P301, P303, P305, P312, P326, P353, P357, P359, P371, P374, P415, P819, P392

• maladaptive feeding P190

• mania P270, P341, P505

• marijuana P616, P653

• Marijuana Policy P481

• marmoset P13

• mast cells 4.1

• MAT P701

• maternal brain P690

• Maternal Depression 26.4

• maternal immune activation P165, P405, P463

• maternal sensitivity P690

• maternal separation P134

• maternal stress P151

• Matrix Metalloproteinase-9 (MMP-9) P628

• MDMA 2.3, P682

• mechanism-based biomarkers 4, 4.2, 5

• mechanisms 37

• Medial Orbitofrontal Cortex 35.4, P332, P785

• Medial Prefrontal Cortex 22.4, 45, 45.2, 50.3, P12, P89, P109, P195, P213, P300, P537, P599, P612, P659, P795, P802, P808, P830

• Medial septum P710

• Medical Marijuana P606, P633

• medication development 7

• medication-naive first episode psychosis 60.2

• medications 17

• Medium Spiny Neuron 50.2, P67, P190, P655

• MEF2C P234

• Melanin-concentrating hormone P613

• melanocortin P195

• memantine P25

• membership P790

• Memory 4.3, P3, P49, P71, P406, P748

• Memory and Learning P15

• Memory Encoding and Retrieval P663

• Memory engram cell P75, P528

• memory reconsolidation P768

• menopause 4.3, 56.3, P18

• mental disorder 23.3

• Mental health disorders P181

• mental health service use P827

• mental illness 3.1

• mentoring 40

• mesolimbic reward circuitry P182, P190, P592, P617, P730

• meta-analysis P97, P133, P520, P742, P812

• metabolic function P53

• metabolism P648

• metabolites P740

• metabolomics P189, P349

• Methamphetamine 20.2, 34, 34.4, 34.5, P619, P624, P652, P705, P712

• methamphetamine seeking P641

• Methocinnamox P718

• methodologies 3

• methylphenidate P55, P505, P654, P679, P699

• mgluR5 P51

• mice P166, P815

• microbiome 28.2, 33, 53, P334

• microbiota P334

• Microbiota-gut-brain axis P334, P715

• Microdialysis P650

• microglia 28.2, 44.4, 52.2, P24, P114, P129, P278, P306, P360, P379, P416, P558, P624, P644

• microglia engulfment 54.1

• microPET P134

• MicroRNA P747

• midbrain P122

• mild cognitive impairment due to AD P314

• Mild Traumatic Brain Injury P88

• Mindfulness Meditation P145

• miRNA P217

• Mirror Neuron P528

• Mismatch Negativity P464, P514

• Mitochondria P23, P244, P255, P275, P416, P637

• Mitochondrial DNA 44.3

• mitochondrial dysfunction P254

• mitochondrial genetics 44

• Mitochondrial Respiration P23, P302

• Mitophagy P395

• MMN P525

• model systems P706

• Moderators 21.3

• modulator P493

• Molecular imaging 16.5

• molecular neuroscience P173, P293

• Molecular profiling 11.1

• monetary incentive delay task P193

• monkey P380

• monoamine oxidase B P425, P767

• Monoamine Transporters 21.1

• Monoiodoacetate Model of Osteoarthritis P432

• Mood P285, P391, P415, P738

• Mood and cognition P668

• mood disorders P121, P217, P237, P298, P345, P364, P373, P385

• morphine P592, P745

• Mortality P1

• motivated behavior 11, 11.4

• motivation P73, P122, P294, P534

• motivational P780

• motor activity P121

• mouse P13

• mouse genetics P735

• Mouse models 28, 34.4, P292, P295, P426, P596

• mPFC 39.4, P134

• MR spectroscopy P385, P483, P538

• MRSI P284

• mtDNA P395

• mTORC1 P273

• Multi-electrode arrays P47

• multimodal data P131

• Multimodal Neuroimaging 37.5

• Multi-omics P349

• multivariate P106

• multivariate analysis 38.3, P469, P703

• mu-opioid receptor agonist P667

• mu-opioid receptor binding potential P391

• mu-opioid receptors 42.2, P339, P600, P732, P819

• Muscarinic agonist P510

• muscarinic M4 P493, P500

• MVPA P473

• Myelin Imaging P107

• Myelination 14.1

• N-acetylcysteine P628

• NACHO P617

• naloxone P750

• Narcissistic traits P202

• native americans 51.2, P287

• Natural Compound P365

• natural language processing (NLP) P62, P465, P496

• naturalistic drug cues P625

• NCANDA P763

• N-desmethylclozapine P568

• near-infrared light P280

• Negative affect 46.3, P730

• negative allosteric modulator P623

• negative emotionality P605

• negative reinforcement P408

• negative symptoms P480, P498, P546, P554, P821

• Negative urgency 46.3, P304

• negative valence P442

• Negative Valence System 37.4, P385

• Neighborhood Crime P168

• Neighborhood Poverty P65

• Network activity 30.2, P331

• Network Modeling 3.2

• network neuroscience 3.2, P791

• Network-Analysis 3.2

• Neural circuit and animal behavior P683

• neural circuitry P128, P820

• neural circuits 30.3, P308, P346

• Neural connectivity 14.2, P184

• Neural coordination P662

• Neural network connectivity P140

• Neural networks P63, P799

• neural oscillations 57.3, P198

• neural plasticity P459

• Neural Predictors P494

• neural progenitor cells P303

• neurite density 14.1

• Neuro P253

• neuroactive steroid P222, P223, P224, P235, P271, P283

• neuroanatomy P201, P441, P570

• neurobiology 38.3

• neurocircuitry 47

• neurocognition P132, P341, P469

• Neurocognitive functioning P687

• neurodegeneration P427

• Neurodegenerative Disease 56.4, P5

• neurodevelopment 28.4, 38.2, 44.5, P107, P116, P151, P186, P486

• neurodevelopment & aging 4

• Neurodevelopmental Disorders 5, 16, P105, P120, P124

• neuroeconomics P342

• Neuroendocrine 10.2

• Neuroendocrine responses P783

• neuroendocrinology 53.3

• Neurofeedback 43, 43.2, P447, P473

• Neurofibrillary tangle P782

• Neurogenesis 11.1, 52.2, P529

• Neurogenesis enhancers P56

• neurogenetics 38.2

• Neuroimage P631

• neuroimaging 2, 7, 23.4

• neuroimaging biomarkers 21.2, P386, P506, P803

• neuroimmune 31, P329, P734

• neuroimmune activation 6.2, P592, P611, P781

• neuroimmune interaction P674

• neuroimmune mechanisms 31.3, P178

• neuroimmune mechanisms: prenatal to aging 4

• Neuroimmunology P416

• Neuroinfection P411

• neuroinflammation 4.1, 6, 23, 34, 52.5, P29, P161, P180, P305, P422, P530, P543, P624, P770, P815

• Neurokinin P263

• neuromarkers 31.5, P749

• Neuromelanin-sensitive MRI P9, P10

• Neurometabolism P820

• Neurometrics P511

• neuromodulation 9.1, 30.5, P280, P759

• neuromodulators 42

• Neuron P303

• neuronal ensemble 45.4

• Neuronal Epigenome 41.2, P108

• Neuronal Oscillations P356, P464

• Neuronal stem cells (NSCs) P401

• neuron-derived exosomes (NDE) P248

• neuropathic pain P420

• neuropathology 23.2, 48.3, 48.4

• neuropeptides 39.2, P212, P263, P764

• neuropharmacology P209, P308

• neurophysiology P177, P215, P384, P724, P792

• Neuroplasticity 2.3, P320, P525, P811

• neuroprotection P424

• Neuropsychiatric Disorders 56.1, 57.4, P428

• Neuropsychiatric Disorders [Schizophrenia, Parkinson’s Disease, Major Depressive Disorder] 57.5, P461, P530

• Neuropsychiatric symptoms (NPS) 48.4, P791

• neuropsychiatry P328

• neuropsychopharmacology P784

• Neurosteroid 10.5, 31.2, 31.3, 31.4

• Neurostimulation P198, P280

• neurosurgery for psychiatric disorders 35.5

• Neurotensin P267, P596

• neurotransmitter co-release P380

• Neurotransmitters 30.4

• Neurovascular coupling P148

• new drug development P742

• next generation sequencing P411

• NFIA P358

• nicotine P589, P623, P815

• nicotine addiction P617, P623, P660, P670, P716, P781

• nicotine dependence P475, P706

• nicotine vapor P706

• nicotine withdrawal P660

• nicotine/substance use disorder P642

• nicotinic acetylcholine receptors P617, P642, P658

• NIH 59

• NIH HEAL Initiative P432

• nitric oxide P296

• NMDA Antagonists P245

• NMDA glutamate receptors P246, P311

• NMDA Receptor 6.5, P431, P471, P525, P574

• NMDAR antagonist P239

• NODDI 14.1

• non pharmacological interventions 55.4

• noncoding RNA P634, P744

• Nonhuman Primates 35.2, P78, P201

• non-invasive brain stimulation 55.3, P232

• Non-invasive Neuromodulation P384, P729

• Non-opioid, Non-addictive Therapeutics P429, P432

• non-parametric item response theory P516

• Non-Suicidal Self-injury (NSSI) P115

• noradrenergic P126

• Noradrenergic System 56, P681

• norepinephrine P10, P437, P691

• novel antidepressant P56

• novel assessment tools for clinical trials P160

• Novel coronavirus (SARS-CoV-2) 23.2, P411, P419, P424

• novel object recognition 56.4

• Novel Targets P563

• novel therapeutics 15, P83, P283, P618, P753

• novelty response P641

• novelty seeking P641

• Nrxn1-alpha 4.1

• nuclear factor kappa B P48

• Nucleus Accumbens 29.2, 29.3, 29.4, 34.2, P128, P190, P207, P221, P230, P294, P342, P352, P387, P598, P621, P626, P629, P637, P655, P665, P743, P781, P823

• nucleus accumbens core P649, P713

• nucleus reuniens P268

• Nucleus tractus solitarii P698

• Obesity P191, P194, P197, P240

• Obesity and eating disorders 46.3

• Obsessive Compulsive Disorder (OCD) 1.3, 35.4, 35.5, 50, 50.2, 50.4, 50.5, P433, P436, P437, P438, P440, P442, P443, P444

• Obsessive-Compulsive and Related Disorders 1.2

• Obsessive-compulsive personality traits P434

• obsessive-compulsive spectrum disorders (OCDS) 1.3

• Obsessive-compulsive symptoms 1.1

• obstructive sleep apnea P585

• OCD phenotypes P434

• older adults 8.4, P29, P231, P406

• ondansetron 17.2

• ontogeny 11

• Open neuroscience 49

• Operant behavior P608, P725, P743

• opiate addiction P765

• opiates P782

• Opioid abuse P601, P608, P612, P627, P650, P688, P732

• Opioid addiction 20, 20.3, 20.5, 42.3, 45.5, P429, P588, P592, P594, P601, P602, P665, P715, P738, P744, P746, P779

• Opioid antagonist treatment P16

• opioid dependence P730

• Opioid peptides 45, P779

• opioid side-effects P667

• Opioid system 42.3

• opioid use disorder 20.2, 20.4, P583, P621, P690, P694, P731, P735, P748, P753, P765, P819

• opioid withdrawal 20.5, P615, P676

• opioids 42, P16, P701, P727, P728, P765, P776

• OPRM1 P102

• Optimism P738

• optogenetics 11.3, 39, P39, P216, P337, P743, P768

• oral antipsychotics 19

• orbitofrontal cortex (OFC) 22.3, 50.4, P90, P622, P645, P663, P684, P702, P785, P821

• orexin 20.4, P659

• orexin receptor P659

• orexin receptor antagonist 20, 20.4, P188

• orexin/hypocretin 20.2, 20.3

• organic cation transporters P671

• outbred rats P677, P739

• ovarian hormones 53.1, P351

• oxidative DNA damage P381

• oxidative stress P211

• oxycodone 20, P694, P721

• oxytocin receptor P157

• p factor P135

• PACAP P35, P553, P649

• Pain 30, 30.3, 42, P176, P408, P606, P612, P633, P701

• Pain sensitivity P161, P366, P412

• Pain therapeutics P420, P805

• pair bond 39.5, P809

• panss P524

• paradigm 38.3

• parahippocampal place area (PPA) P551

• paraventricuar nucleus P136

• paraventricular nucleus of the hypothalamus P683

• paraventricular nucleus of the thalamus P267, P621

• Parent - child dyads 26, 26.2, 26.3, P206

• parietal cortex P816

• Parkinson’s disease P265, P426

• Parkinson’s Disease and Dementia Psychosis P426

• partial agonist P667

• Partial Agonist Ligands P590

• Parvalbumin fast-spiking GABAergic interneurons P599, P609

• parvalbumin interneurons P712, P808

• Parvalbumin neurons P300, P460, P484, P673

• PASC 23.4

• Patient outcomes P240, P494, P555

• pattern separation P56

• Pavlovian conditioning P27, P626, P705

• Pediatric Bipolar Disorder P393

• pediatric irritability P37, P403, P797, P799

• Perceived stress P211, P586, P678, P700

• Perceptual decision-making P535

• periaqueductal grey (PAG) P607

• Perimenopause 10.5, 53.3

• Perinatal stress 44.2

• Perineuronal nets P609, P673, P712

• Peripheral Biomarker P355

• Peripheral blood marker P542

• periventricular thalamus 54

• personal space P816

• personality P682

• personalized medicine 21, 21.1, P595

• Pesticides 44.2

• PET Imaging P10, P19, P210, P391, P668, P716

• PET Imaging Study P51

• PET probe P422

• PFC P752

• pharmacoBOLD P209, P458

• Pharmacodynamics P514

• Pharmacoepidemiology P120

• pharmacogenetics P694

• Pharmacogenomics P371

• Pharmacokinetic and Pharmacodynamic P273

• Pharmacokinetics P159, P518, P716, P742, P805

• Pharmacology 17, P209

• pharmacotherapy 1.3, 17.1, P443, P630, P639, P730

• Phase II clinical trial P429

• Phase III trial P154

• phosphatase P782

• Phosphodiesterase-4 (PDE4) 34, 34.2, 34.4, 34.5

• photobiomodulation P286

• pimavanserin P518

• PKCdelta P86, P711

• placebo-controlled trial 32, P824

• placenta 28.4, 44.2, P118

• Polydrug Use P587

• Polygenetic Risk Score P242, P383, P450, P477, P695

• polygenic risk score 38.3, P132, P363, P540, P819

• polygenic risk scores 25, 28.5, 52.3, P299, P575

• Polygenic scores 13.5

• Polypharmacy P390

• polysomnography P402, P557

• polysubstance abuse P776

• Poor clinical outcome P275

• Population genetics 38.4

• Positive Affect 26.3

• Positive symptoms P554

• positive valence P442

• positron emission tomography (PET) 7, 13.4, 16.4, 41.1, P165, P291, P425, P500, P526, P729, P766, P767, P819

• Post Traumatic Stress Disorder (PTSD) 2.3, 17.1, 31.4, 31.5, 39.2, 41, 41.1, 41.2, 43, 43.2, P31, P38, P48, P49, P51, P53, P57, P59, P61, P65, P66, P67, P70, P79, P83, P91, P93, P94, P97, P98, P99, P100, P167, P247, P382

• Posterior Cingulate Cortex P145

• Postmortem P532, P549, P567

• post-mortem brain P521

• Postmortem Brain Tissue P94, P264, P468

• postoperative cognitive dysfunction P16

• postpartum P578

• postpartum depression P351

• postpartum mood P141

• posttraumatic stress P29

• potential mechanism 13

• pragmatic analysis 8.2

• prairie voles P142, P809

• prazosin P777

• Precision Medicine for Depression P810

• Precision Medicine for Mood and Anxiety Disorders P159

• Precision Medicine for Mood Disorders P310, P355

• Preclinical pharmacology P563

• Preclinical Screening Platform for Pain P420, P432

• precuneus P284

• Predictive Biomarker P70

• predictive coding 2.4

• Predictive Models P250

• prefrontal circuit maturation P13

• prefrontal cortex 35.3, 45.5, 57.2, P78, P295, P342, P344, P448, P464, P543, P594, P635

• Pregabalin P727

• pregnancy 23.4, 53.1, P151, P168, P178

• prelimbic cortex P33, P36, P40, P578, P649, P666, P713, P724, P745

• premenstrual dysphoric disorder P335

• premenstrual syndrome P335

• Prenatal alcohol exposure P138

• Prenatal Drug Exposure P164

• Prenatal exposure 4.3, 28, P142

• Prenatal immune exposures P106, P543

• prenatal stress 28.2, 28.3, P118, P139, P234

• Prepulse Inhibition P25

• pre-school children 9.2

• Prescription Opioids P182, P408, P746

• prevention 26.4, 38.3, P434, P774, P808

• probabilistic reversal learning P771, P800

• Processing speed P487

• prodromal schizophrenia P545

• prodrome 9.1

• Prodynorphin 11.4, P731

• progesterone P351, P820

• Progressive ratio testing P643

• Pro-inflammatory cytokines 31.3, 34.3, 52.2, P411

• projection targets P489

• prophylactic P50

• propranolol P126

• prostaglandin P211

• protein aggregation P449

• protein kinase activity P550

• Proteomics 41.1, P93, P318, P322, P355, P549, P591, P688, P765

• Proteostasis P449

• proton magnetic resonance spectroscopy P307

• provider perspectives 8.4

• Psilocybin 22.4, P181, P229, P350, P353, P654, P784, P796

• Psychedelic medicine 2.5, P229

• Psychedelics 2, 2.4, 15, P181, P225, P348, P365, P382, P627, P654, P796, P800, P818

• Psychiatric Comorbidity 37.4, P177, P307, P703

• psychiatric genetics P428

• psychiatric measurement P100

• psychological distress P81

• Psychological Wellbeing 8.3, P231

• Psychopathology 37, P542, P798

• psychophysiology P42

• psychosis 6.2, 13, 13.2, 13.4, 38, 38.2, 52, 52.3, 60.4, P6, P473, P476, P478, P481, P482, P483, P495, P520, P532, P564, P572, P573

• psychosis risk P571

• psychosocial intervention P156

• psychosocial stress P325, P329, P607

• Psychostimulant P505, P677, P782

• Psychotherapy 2, P448

• Psychotic Disorders P373, P457, P557

• psychotic-like experiences P511

• PTSD depression 15, P18, P72

• Pubertal stress P113

• Puberty P147, P186

• punishment 22.3, P640, P643

• pupillometry P792

• qEEG P144

• QTL P714

• qualitative research 8.4, P333

• Quality of Life P633

• Quantitative Electroencephalography (qEEG) 26, P384

• R-(-)-ketamine P405

• Race disparities 23.5, 27.2

• racial differences 27, P741

• racial ethnic minority 12

• Racism 27.1, 27.3, 59

• Racism and discrimination stress 28.3, P169

• Randomized-Controlled Trial 55.5, P350, P502

• raphe nucleus P426

• Rapid Antidepressant P235, P283

• Rapid Antidepressant Effects P246

• Rapid Cycling P375

• Rapid depression treatment 15

• Rare genetic variants 38.2, 48.1

• Rare genetic variation P445

• Rare Neurodevelopmental Disorders P105, P123

• Rat models P584

• Rating scales P516

• rats P192

• RCT 2, 17.4

• real-time fMRI neurofeedback 43, 43.2, 43.3, 43.4, P122, P145, P467

• recognition memory P166, P641

• recordings P745

• Reinforcement learning P403, P721, P815

• reinstatement P717

• REL-1017 P315

• relapse 13.3, 19, P602, P613, P673

• relapse and treatment outcome P605

• relapse biomarkers 60.3

• Relevance for Outcomes P555

• REM sleep 6.4, P35, P613

• remifentanil P608

• remote assessment solution P228

• Repeated treatment P718

• repetitive transcranial magnetic stimulation (rTMS) 55.4, 55.5, P215, P232, P384, P418, P497, P502, P533

• reproducibility P106

• reproduction 10.3, P410

• Research domain criteria (RDoC) 37, 37.2, P200, P595, P783, P786, P817, P828

• resilience 41, 41.2, 41.3, P98, P715

• Respiration P727

• respiratory safety P585

• response inhibition P702, P797

• Resting and task fMRI P88

• resting state brain dynamics P389

• Resting State Connectivity P104, P631

• Resting State Functional Connectivity 21.2, 35.2, 60.2, P64, P76, P110, P112, P137, P169, P214, P251, P285, P323, P358, P475, P503, P511, P527, P699, P796

• Resting state intrinsic connectivity P261, P282

• Resting-state fMRI P74, P218, P506, P784

• Resveratrol P715

• Retest Reliability P511

• retrograde tracing 35.2

• reversal learning P438

• Reward 1.4, 14, 14.4, 22.5, 29.4, 42.4, P213, P308, P357, P387, P699, P704, P772, P780

• reward and aversion P651

• Reward Anticipation P270

• reward circuitry 29

• reward deficit P128

• reward devaluation P724

• Reward functioning P241, P783

• reward neural circuitry P216

• reward prediction error P403

• Reward processing P393, P561, P648

• Reward Sensitivity P771

• reward system P597

• Reward-based decision-making 25.2

• reward-seeking behavior P745

• Rhesus monkeys P645, P691, P718

• RiboTag P644

• right temporo-parietal junction P527

• Risk 1.4

• Risk and Resilience P113, P119

• Risk Calculator P363

• Risk Evaluation and Mitigation Strategy (REMS) P225

• Risk factors 10.5

• risk taking behaviors P684

• risk-taking P695

• Risky decision-making P640

• RNA binding protein P15

• RNA Sequencing P300, P723

• RNAscope fluorescence in situ hybridization P45, P484

• RNAseq P78, P236, P276, P351, P598, P644, P772, P794

• rodent P617

• Rodent models 41.1, P410

• rsfMRI functional connectivity P368

• rubber hand illusion P454

• rumination 21.3, P389

• Safety P224

• Salience P112

• salience network 55.4, P201

• SAPAP3 50, 50.3

• SAPAP3 KO mice P442

• scanner harmonization P487

• Schizophrenia (SCZ) 6, 6.4, 13.5, 19, 28.4, 32, 33, 38.4, 38.5, 48, 48.1, 48.2, 52, 52.4, 60.2, P423, P449, P451, P456, P457, P458, P460, P463, P465, P467, P470, P475, P478, P479, P484, P486, P487, P491, P493, P494, P495, P496, P497, P498, P499, P500, P502, P504, P510, P512, P514, P517, P518, P521, P532, P533, P536, P537, P539, P541, P543, P546, P549, P550, P551, P552, P554, P561, P563, P566, P567, P568, P569, P575, P576, P577, P755

• schizophrenia and bipolar disorders P477, P544, P803

• schizophrenia negative symptoms P491, P560

• Schizophrenia novel treatment 55.5, P472, P507, P553, P579

• schizophrenia spectrum disorders P453, P469, P509

• Schizophrenia subtypes 52.5

• Schizophrenia-like Behavior P405, P471

• selective attention P551

• Selective Serotonin Reuptake Inhibitors (SSRIs) 2.5, P159, P259, P262, P367

• Self-Administration 25, 34.5, 45.4, P584, P596, P623, P647, P656, P701, P705, P718, P721

• Self-esteem P391

• self-injury P817

• Self-medication with psychedelics P181

• self-other processing 43.4

• self-referential P817

• self-referential processing 2.4, P243

• Sensitive Period 28, 54.2, P446

• Sensitivity P686

• Sensory Processing P419

• Septal area 11.1

• sequencing 48.1, P566, P575

• serious mental illness P773

• Serotonin 30.4, 56, 56.2, P45, P47, P192, P229, P345, P645, P691, P751

• serotonin 1A receptors P192, P259, P317, P645

• Serotonin 5-HT2A Receptor P800

• Serotonin 5-HT2C Receptor 42.1, P192

• serotonin and norepinephrine reuptake inhibitor P262, P367

• Serotonin Transporter P210

• Sertraline P371

• severe mental illness P383

• sex P361

• sex differences 4, 4.3, 10.2, 22.2, 25.1, 41, 58, P7, P8, P23, P70, P73, P80, P81, P148, P150, P220, P269, P285, P294, P301, P317, P340, P360, P370, P466, P583, P615, P621, P640, P643, P651, P658, P684, P685, P692, P710, P766, P781, P809

• Sex Hormones P80, P416, P762

• sex pairing P757

• sex-specific P417

• Sexual Dimorphism 4.2, P2

• Shank3-deficient mice 16.2

• Sigma2, 5 HT2, Alpha receptors P546

• sign-tracking P626, P705

• Simultaneous PET-MR P388, P699, P709

• Single cell P91

• single cell omics P94, P611

• Single-cell RNA sequencing 11.1, 29, 42.2, P95, P138, P290, P339, P688, P689

• single-cell sequencing 29.4

• single-nucleus RNA-seq P264, P276

• Skin conductance responses P31

• SLC39A8 P451

• SLC6A1/GAT1 P423

• sleep P11, P285, P402, P409, P586

• sleep architecture P581, P582

• Sleep disturbances P72, P583

• Sleep inconsistency P632

• sleep spindles P472, P522, P557

• slow oscillation P522

• slow wave sleep P35

• smartphone P214

• Smell P680

• smoking 17.4, 55.2

• Smoking Cessation 17.3, 55, P668, P670

• SNP P220

• SNP variation P445

• sociability P808

• social anhedonia P515

• social anxiety P71

• Social Behavior 11.2, 11.3, 26, P33, P129, P212, P309, P331, P395, P661, P662, P795, P830

• social cognition P469, P578, P807

• social defeat P607

• Social defeat stress P249, P352

• Social Deficits 16.2, P154

• social determinants of health 12, 23.5

• social dominance P309

• Social Factors and Functioning P57

• Social hierarchy 39.4

• Social Interactions 14.3, P126, P757, P802

• social isolation 39, 39.3, P672

• social isolation stress 39.2, P594, P787

• social motivation 39, 39.3

• Social rejection P71, P325, P391

• social status P317

• social stress P252, P309

• Social support 51.2

• Somatostatin P484, P666

• spatial memory P529

• spatial transcriptomics P96, P264, P611

• speech development P141

• Spinal Cord P419

• splice variants P396

• Startle P242, P786

• statistical methods P250

• stem cells P303

• Stimulants P198, P728, P776

• stimulus enhancement P750

• stimulus inhibition P750

• stop-signal P203

• Stress P68, P168, P213, P336, P370, P388, P396

• Stress abnormalities P268

• Stress and anxiety behavior P344, P683

• Stress and Depression P263

• Stress and Trauma 28.3, P57, P62, P153, P696

• Stress Coping P632, P683

• stress hormones P622

• Stress models 4.2

• Stress reactivity P722, P825

• stress resilience 10.3, P68, P266, P295, P320, P346

• stress resilience and susceptibility P290, P342, P347

• Striatal Dopamine signaling 13.4, P526

• striatal functional connectivity 60

• striatum 50.2, P27, P191, P282, P330, P532, P617

• Structural Connectivity P197

• Structural MRI 44.5, P42, P70, P162, P474

• structural racism 12

• Subcortical Shape Analysis P486

• Subcutaneous Fat P453

• subgenual anterior cingulate P430

• Subjective Response P685, P734

• subliminal emotion P115

• Substance abuse P556, P760

• Substance abuse disorders 10.3, P652, P719

• Substance P P52

• substance use disorder 23.3, 29, P610, P627, P669, P696, P714, P728, P737, P739, P773

• Substance-related disorders P677

• Subtypes of substance use disorder P595

• SUD risk 23

• SUD-like phenotypes P761

• Suicidal behavior 21.3, P296

• suicidal ideation P237, P247, P364

• Suicidality 9, P240, P287

• suicide 9.3, P34, P133, P144, P313, P402

• Suicide attempt P184, P349, P358, P364, P376

• Suicide prediction P131, P364

• Suicide risk factors P281

• Superresolution and deconvolution microscopy 30.5

• supplementary motor cortex P533

• suprachiasmatic nucleus P180

• sustained threat of shock P185

• switching strategies 8

• symptomatology P564

• synapses P23, P265

• Synaptic Plasticity 2, 2.2, 45.5, P3, P52, P67, P182, P311, P462, P609, P621

• synaptic pruning P114

• Synchrony 26.3

• synspsis P396

• systemic inflammation P64

• systems neurobiology P494

• systems neuroscience 25

• TAAR1 P491, P517

• tactile mismatch 2.4

• tandem repeat variation P521

• Target engagement P507

• targeted cognitive training P562, P827

• task fMRI P455

• Taste P680

• tau 56.1, 56.2, P409

• Technology P555

• telemedicine P556

• temperament 44.3

• temperature P409

• Test-Retest Reliability P476

• thalamo-cortical connectivity P564

• Thalamo-cortical Interactions P537

• Thalamus 45.2, 54.3, P24, P260, P393, P784

• Thalamus - Reticular nucleus P522

• THC P589, P620, P631, P651, P682, P755

• the COVID-19 pandemic 37.5, P81, P272, P678, P816

• theory of mind P527

• therapeutic target P93

• theta P503

• theta band oscillatory measures P470

• Theta-burst stimulation 50, 50.4, P232

• Threat of Shock P260, P786

• thyroid hormone 10

• tianeptine P292

• Tic disorders P421

• time-frequency P436, P470, P669

• Tissue Transcriptomics P419

• TMS EEG P321

• Tolerability P224

• tolerance P348

• Toll-Like receptors (TLRs) 31.3, P16, P592

• top-down control P710

• total energy P286

• Tourette syndrome P421, P423, P437

• Trace amines-associated receptor 1 P705

• T-RAD Study P20

• training P525

• transcranial direct current stimulation P652

• transcranial magnetic stimulation (TMS) 50, 50.5, 55.2, P250, P323, P392

• transcranial photobiomodulation P280

• Transcriptome 28.4, P91, P636, P698

• Transcriptomics 29.3, 39, P123, P134, P360, P657, P730, P794

• transcutaneous auricular vagus nerve stimulation (taVNS) P326

• Transdiagnostic P433, P791, P804, P827

• Transgender 24

• Transgenic rats 45.3, P711

• translational 37, P62

• Translational approaches to drug development 5, P311

• Translational biomarker approaches to drug development P235

• translational imaging P137

• Translational Neuroscience 57, 57.3

• transsynaptic P713

• TRAP2 mice P69

• Trauma P84

• Trauma exposure 27.1, 41.3, P34, P788

• Traumatic Brain Injury (TBI) P5, P24, P45, P425

• Traumatic stress 51, P783

• Treatment Prediction P749

• treatment refractory P480

• treatment resistance 8

• Treatment Resistant Depression 8.2, 8.3, 21.2, P231, P273, P392

• treatment targets P669

• Treatment-resistance P350

• Treatment-resistant depression 8.4, P245, P376

• treatment-resistant late life depression 8.4, P328

• treatment-resistant schizophrenia 48.1, P566

• Treatment-Response P215, P227, P457

• tricyclics P262

• T-type Calcium channel P472

• Two-photon P337

• Two-photon calcium imaging 45.4, P785

• Type-2 Diabetes P53

• Ubiquitin Proteasome System P449

• ubiquitination P449

• ultrasonic vocalization P157

• Uncinate Fasciculus 54.3

• Unconditioned responses P31

• underrepresented 59

• unpredictability 54.2

• valence P267, P337, P655

• validity P524

• Value-based Decision-Making P738, P787, P792

• Vapor P651

• Varenicline 17.3

• variability in brain activity pattern P497

• vascular 23.2

• Vasopressin 1a receptor antagonist P154

• ventral attention P28

• ventral hippocampus P50, P269, P489, P626

• Ventral Pallidum P73, P256, P615, P673

• Ventral Striatum P408, P571

• Ventral tegmental area (VTA) 29.5, 57.5, P594, P689

• ventral visual stream P439

• ventrolateral prefrontal cortex 35, P270

• ventromedial prefrontal cortex P788

• veterans 17.1, P34, P477

• VGluT2 neurons P427

• VIP neurons P331

• virtual reality P562, P816

• Visceral Fat P453

• visual cortex P464

• visual modulation P439

• visual perception P483

• visuospatial working memory P531

• vlPFC P201

• vole 39.5

• voltage indicator 30, 30.2

• Voxel-Based Morphometry (VBM) 48.3, P156

• VPAC2 receptor antagonist P553

• vulnerability and resilience 37.5

• Vulnerability traits P153

• waist circumference P335

• White Matter 14.1, 27.2, P111

• White Matter Development P107

• white matter integrity P586

• white matter microstructure P85

• WHO risk levels P610

• Whole exome sequencing 48, P146

• whole genome sequence P521

• whole-genome 48.1, P566, P575

• williams syndrome P147

• withdrawal P730, P759

• Within-pair concordance 26.2

• Wnt signaling P236

• women P48

• women’s health P76, P707

• Women’s Mental Health P18, P820

• working memory 6.5, P568, P620, P712

• working memory fMRI P497

• World Trade Center responders P98

• Worry P74

• young adults P332

• youth P133

• zebrafish P171

• Zinc P175

• zuranolone P222, P223, P224, P271